π
|
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
22 auth.
I. Perea-Gil,
T. Seeger,
A. Bruyneel,
Vittavat Termglinchan,
Emma Monte,
Esther W. Lim,
Nirmal Vadgama,
T. Furihata,
A. A. Gavidia,
J. Arthur Ataam,
...
NikΓ« Bharucha,
Noel Martinez-Amador,
M. Ameen,
Pooja Nair,
Ricardo Serrano,
B. Kaur,
D. Feyen,
S. Diecke,
M. Snyder,
Christian M. Metallo,
M. Mercola,
I. Karakikes
|
5 |
2022 |
5 π
|
π¦
|
A deep learning platform to assess drug proarrhythmia risk.
12 auth.
Ricardo Serrano,
D. Feyen,
A. Bruyneel,
A. Hnatiuk,
Michelle M Vu,
Prashila L. Amatya,
...
I. Perea-Gil,
Maricela Prado,
T. Seeger,
Joseph C. Wu,
I. Karakikes,
M. Mercola
|
3 |
2022 |
3 π¦
|
π
|
Reengineering Ponatinib to Minimize Cardiovascular Toxicity
19 auth.
A. Hnatiuk,
A. Bruyneel,
Dhanir Tailor,
Mallesh Pandrala,
Arpit Dheeraj,
Wenqi Li,
Ricardo Serrano,
D. Feyen,
Michelle M Vu,
Prashila L. Amatya,
...
Saloni Gupta,
Y. Nakauchi,
I. Morgado,
V. Wiebking,
R. Liao,
M. Porteus,
R. Majeti,
Sanjay V. Malhotra,
M. Mercola
|
3 |
2022 |
3 π
|
π¬
|
Abstract Mo085: Direct effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on cardiomyocyte function as a potential therapy for Phospholamban cardiomyopathy
A. Hnatiuk,
Alexander Li,
David Staudt,
Ricardo Serrano,
M. Mercola
|
0 |
2024 |
0 π¬
|
π¬
|
Uncertainty-Aware Traction Force Microscopy
Adithan Kandasamy,
Yi-Ting Yeh,
Ricardo Serrano,
M. Mercola,
J. C. del Γlamo
|
0 |
2024 |
0 π¬
|